Compounds and methods for treating seizure and paroxysmal disorders

Details for Australian Patent Application No. 2005258021 (hide)

Owner Wisconsin Alumni Research Foundation

Inventors Stafstrom, Carl E.; Roopra, Avtar S.; Kriegler, Steven M.; Sutula, Thomas P.

Agent Spruson & Ferguson

Pub. Number AU-B-2005258021

PCT Pub. Number WO2006/002121

Priority 60/580,436 17.06.04 US

Filing date 17 June 2005

Wipo publication date 5 January 2006

Acceptance publication date 18 December 2008

International Classifications

A61K 31/7004 (2006.01) - Monosaccharides having only carbon, hydrogen and oxygen atoms

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/002121 Priority application(s): WO2006/002121

18 December 2008 Application Accepted

  Published as AU-B-2005258021

23 April 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005258025-Indolylalkylamine metabolites as 5-hydroxytrytamine-6 ligands

2005258017-Lactam tachykinin receptor antagonists